BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 21, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
New formulation of rhGH from Alkermes and Genentech
July 12, 1996
KGR-1380: A novel glycation inhibitor
July 12, 1996
Aldose reductase inhibitors described by Grelan
July 12, 1996
Optro enters U.S./Canadian phase II trials
July 12, 1996
Pharmacia & Upjohn terminates Hemopure codevelopment agreement
July 12, 1996
Results of fat accumulation/PAI-1 levels relationship study disclosed
July 12, 1996
Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb
July 12, 1996
(+)-Sch-58053: Schering-Plough's cholesterol absorption inhibitor
July 12, 1996
Pfizer and Warner-Lambert sign atorvastatin agreement
July 12, 1996
Cathepsin B and L inhibitors in Fujisawa's pipeline
July 12, 1996
Previous
1
2
…
1745
1746
1747
1748
1749
1750
1751
1752
1753
…
1765
1766
Next
RSS